- A phase I clinical trial of spicamycin derivative KRN5500 (NSC 650426) using a phase I accelerated titration "2B" design. Gadgeel, S.M., Boinpally, R.R., Heilbrun, L.K., Wozniak, A., Jain, V., Redman, B., Zalupski, M., Wiegand, R., Parchment, R., LoRusso, P.M. Investigational new drugs. (2003)